Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion

Linda E. Krach, Robert L. Kriel, Richard C. Gilmartin, Dale M. Swift, Bruce B. Storrs, Ira Richmond Abbott, III, John D. Ward, Karen K. Bloom, William H. Brooks, Joseph R. Madsen, John F. McLaughlin, Joseph M. Nadell

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The purpose of this study was to assess whether reduction of muscle tone by continuous intrathecal baclofen infusion affects the progression of hip subluxation in persons with cerebral palsy. This prospective, open-label, case series was conducted at multiple specialty referral centers. There were 33 subjects, ages 4 to 31 years. All had a pretreatment lower extremity Ashworth score of ≥3; all subjects had a significant reduction in tone after a bolus injection of intrathecal baclofen and received an implanted pump for continuous delivery of intrathecal baclofen. Subjects had hip x-rays before and 1 year after pump implantation. The primary outcome measure was change in absolute hip migration percentage. One third of the hips had an increase of absolute migration percentage of 5% or more; 12% of the hips had a decrease of migration percentage of 5% or more. Change of migration percentage class was used as a second outcome criterion. 90.9% of hips manifested no deterioration or had improvement of their migration percentage class during the year of intrathecal baclofen therapy. The observed changes were not associated with the subject's age or the severity of cerebral palsy.

Original languageEnglish (US)
Pages (from-to)163-168
Number of pages6
JournalPediatric Neurology
Volume30
Issue number3
DOIs
StatePublished - Mar 2004
Externally publishedYes

Fingerprint

Baclofen
Cerebral Palsy
Hip
Spinal Injections
Lower Extremity
Referral and Consultation
X-Rays
Outcome Assessment (Health Care)
Muscles

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology

Cite this

Krach, L. E., Kriel, R. L., Gilmartin, R. C., Swift, D. M., Storrs, B. B., Abbott, III, I. R., ... Nadell, J. M. (2004). Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion. Pediatric Neurology, 30(3), 163-168. https://doi.org/10.1016/j.pediatrneurol.2003.08.006

Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion. / Krach, Linda E.; Kriel, Robert L.; Gilmartin, Richard C.; Swift, Dale M.; Storrs, Bruce B.; Abbott, III, Ira Richmond; Ward, John D.; Bloom, Karen K.; Brooks, William H.; Madsen, Joseph R.; McLaughlin, John F.; Nadell, Joseph M.

In: Pediatric Neurology, Vol. 30, No. 3, 03.2004, p. 163-168.

Research output: Contribution to journalArticle

Krach, LE, Kriel, RL, Gilmartin, RC, Swift, DM, Storrs, BB, Abbott, III, IR, Ward, JD, Bloom, KK, Brooks, WH, Madsen, JR, McLaughlin, JF & Nadell, JM 2004, 'Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion', Pediatric Neurology, vol. 30, no. 3, pp. 163-168. https://doi.org/10.1016/j.pediatrneurol.2003.08.006
Krach, Linda E. ; Kriel, Robert L. ; Gilmartin, Richard C. ; Swift, Dale M. ; Storrs, Bruce B. ; Abbott, III, Ira Richmond ; Ward, John D. ; Bloom, Karen K. ; Brooks, William H. ; Madsen, Joseph R. ; McLaughlin, John F. ; Nadell, Joseph M. / Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion. In: Pediatric Neurology. 2004 ; Vol. 30, No. 3. pp. 163-168.
@article{fe2c4d690bc940bca5cf4b93e4fefbeb,
title = "Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion",
abstract = "The purpose of this study was to assess whether reduction of muscle tone by continuous intrathecal baclofen infusion affects the progression of hip subluxation in persons with cerebral palsy. This prospective, open-label, case series was conducted at multiple specialty referral centers. There were 33 subjects, ages 4 to 31 years. All had a pretreatment lower extremity Ashworth score of ≥3; all subjects had a significant reduction in tone after a bolus injection of intrathecal baclofen and received an implanted pump for continuous delivery of intrathecal baclofen. Subjects had hip x-rays before and 1 year after pump implantation. The primary outcome measure was change in absolute hip migration percentage. One third of the hips had an increase of absolute migration percentage of 5{\%} or more; 12{\%} of the hips had a decrease of migration percentage of 5{\%} or more. Change of migration percentage class was used as a second outcome criterion. 90.9{\%} of hips manifested no deterioration or had improvement of their migration percentage class during the year of intrathecal baclofen therapy. The observed changes were not associated with the subject's age or the severity of cerebral palsy.",
author = "Krach, {Linda E.} and Kriel, {Robert L.} and Gilmartin, {Richard C.} and Swift, {Dale M.} and Storrs, {Bruce B.} and {Abbott, III}, {Ira Richmond} and Ward, {John D.} and Bloom, {Karen K.} and Brooks, {William H.} and Madsen, {Joseph R.} and McLaughlin, {John F.} and Nadell, {Joseph M.}",
year = "2004",
month = "3",
doi = "10.1016/j.pediatrneurol.2003.08.006",
language = "English (US)",
volume = "30",
pages = "163--168",
journal = "Pediatric Neurology",
issn = "0887-8994",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion

AU - Krach, Linda E.

AU - Kriel, Robert L.

AU - Gilmartin, Richard C.

AU - Swift, Dale M.

AU - Storrs, Bruce B.

AU - Abbott, III, Ira Richmond

AU - Ward, John D.

AU - Bloom, Karen K.

AU - Brooks, William H.

AU - Madsen, Joseph R.

AU - McLaughlin, John F.

AU - Nadell, Joseph M.

PY - 2004/3

Y1 - 2004/3

N2 - The purpose of this study was to assess whether reduction of muscle tone by continuous intrathecal baclofen infusion affects the progression of hip subluxation in persons with cerebral palsy. This prospective, open-label, case series was conducted at multiple specialty referral centers. There were 33 subjects, ages 4 to 31 years. All had a pretreatment lower extremity Ashworth score of ≥3; all subjects had a significant reduction in tone after a bolus injection of intrathecal baclofen and received an implanted pump for continuous delivery of intrathecal baclofen. Subjects had hip x-rays before and 1 year after pump implantation. The primary outcome measure was change in absolute hip migration percentage. One third of the hips had an increase of absolute migration percentage of 5% or more; 12% of the hips had a decrease of migration percentage of 5% or more. Change of migration percentage class was used as a second outcome criterion. 90.9% of hips manifested no deterioration or had improvement of their migration percentage class during the year of intrathecal baclofen therapy. The observed changes were not associated with the subject's age or the severity of cerebral palsy.

AB - The purpose of this study was to assess whether reduction of muscle tone by continuous intrathecal baclofen infusion affects the progression of hip subluxation in persons with cerebral palsy. This prospective, open-label, case series was conducted at multiple specialty referral centers. There were 33 subjects, ages 4 to 31 years. All had a pretreatment lower extremity Ashworth score of ≥3; all subjects had a significant reduction in tone after a bolus injection of intrathecal baclofen and received an implanted pump for continuous delivery of intrathecal baclofen. Subjects had hip x-rays before and 1 year after pump implantation. The primary outcome measure was change in absolute hip migration percentage. One third of the hips had an increase of absolute migration percentage of 5% or more; 12% of the hips had a decrease of migration percentage of 5% or more. Change of migration percentage class was used as a second outcome criterion. 90.9% of hips manifested no deterioration or had improvement of their migration percentage class during the year of intrathecal baclofen therapy. The observed changes were not associated with the subject's age or the severity of cerebral palsy.

UR - http://www.scopus.com/inward/record.url?scp=12144290510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144290510&partnerID=8YFLogxK

U2 - 10.1016/j.pediatrneurol.2003.08.006

DO - 10.1016/j.pediatrneurol.2003.08.006

M3 - Article

VL - 30

SP - 163

EP - 168

JO - Pediatric Neurology

JF - Pediatric Neurology

SN - 0887-8994

IS - 3

ER -